HRTX
Heron Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.16 / 10
Netural
HRTX's fundamental rating is neutral (4.2/10). Key strengths include a solid interest-coverage ratio (15.5%) and positive asset-MV score, suggesting prudent financial health. However, inventory turnover remains weak (0.49), and several valuation metrics (e.g., PB-ROE) lag, tempering overall appeal. Historical back-tests show mixed monthly returns, reinforcing the need for vigilance.
Analysis Checks(10/10)
Revenue-MV
Value0.11
Score3/3
Weight21.59%
1M Return11.03%
Value0.11
Score3/3
Weight21.59%
1M Return11.03%
Inventory turnover ratio
Value0.49
Score3/3
Weight-1.69%
1M Return-1.05%
Value0.49
Score3/3
Weight-1.69%
1M Return-1.05%
PB-ROE
Value-0.28
Score2/3
Weight23.20%
1M Return10.90%
Value-0.28
Score2/3
Weight23.20%
1M Return10.90%
Operating revenue (YoY growth rate %)
Value10.45
Score2/3
Weight0.16%
1M Return0.10%
Value10.45
Score2/3
Weight0.16%
1M Return0.10%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.48%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.48%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value10.45
Score3/3
Weight1.39%
1M Return0.88%
Value10.45
Score3/3
Weight1.39%
1M Return0.88%
Profit-MV
Value0.47
Score2/3
Weight17.33%
1M Return8.99%
Value0.47
Score2/3
Weight17.33%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-1.87%
1M Return-1.25%
Value15.51
Score2/3
Weight-1.87%
1M Return-1.25%
Asset-MV
Value-0.51
Score2/3
Weight24.72%
1M Return12.15%
Value-0.51
Score2/3
Weight24.72%
1M Return12.15%
Cash-MV
Value-1.83
Score2/3
Weight16.64%
1M Return8.80%
Value-1.83
Score2/3
Weight16.64%
1M Return8.80%
Revenue-MV
Value0.11
Score3/3
Weight21.59%
1M Return11.03%
Value0.11
Score3/3
Weight21.59%
1M Return11.03%
Total operating revenue (YoY growth rate %)
Value10.45
Score3/3
Weight1.39%
1M Return0.88%
Value10.45
Score3/3
Weight1.39%
1M Return0.88%
Inventory turnover ratio
Value0.49
Score3/3
Weight-1.69%
1M Return-1.05%
Value0.49
Score3/3
Weight-1.69%
1M Return-1.05%
Profit-MV
Value0.47
Score2/3
Weight17.33%
1M Return8.99%
Value0.47
Score2/3
Weight17.33%
1M Return8.99%
PB-ROE
Value-0.28
Score2/3
Weight23.20%
1M Return10.90%
Value-0.28
Score2/3
Weight23.20%
1M Return10.90%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-1.87%
1M Return-1.25%
Value15.51
Score2/3
Weight-1.87%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value10.45
Score2/3
Weight0.16%
1M Return0.10%
Value10.45
Score2/3
Weight0.16%
1M Return0.10%
Asset-MV
Value-0.51
Score2/3
Weight24.72%
1M Return12.15%
Value-0.51
Score2/3
Weight24.72%
1M Return12.15%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.48%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.48%
1M Return-0.98%
Cash-MV
Value-1.83
Score2/3
Weight16.64%
1M Return8.80%
Value-1.83
Score2/3
Weight16.64%
1M Return8.80%
Is HRTX fundamentally strong?
- HRTX scores 4.16/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -8.75% net margin, -17.02 P/E ratio, 15.52 P/B ratio, and 43.75% earnings growth, these metrics solidify its Netural investment rating.
